| Product Name | MF | CAS | Details |
|---|
| (2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester | C27H38N6O3S | 401566-80-1 | Details |
| 2,3-Dihydro-1H-phenalen-1-one | C13H10O | 518-85-4 | Details |
| Etelcalcetide | C38H73N21O10S2 | 1262780-97-1 | Details |
| 1-(Aminomethyl)-N,N-dimethylcyclobutane-1-carboxamide hydrobromide | C8H17BrN2O | 1803600-46-5 | Details |
| 4,6-Dichloro-N-methylpyrimidin-2-amine | C5H5Cl2N3 | 10397-15-6 | Details |
| Schisanlactone C | C30H40O5 | 92051-27-9 | Details |
| Arbekacin sulfate | C22H46N6O14S | 104931-87-5 | Details |
| 3-((4-(2-pyridylthio)phenyl)amino)cyclohex-2-en-1-one | C17H16N2OS | 634155-00-3 | Details |
| Hexyl b-D-maltopyranoside | C18H34O11 | 870287-95-9 | Details |
| 3-Bromo-4-chloroaniline | C6H5BrClN | 823-54-1 | Details |
| 2-(4-Methoxyphenyl)ethane-1-sulfonamide | C9H13NO3S | 76653-15-1 | Details |
| Ethyl[(3-fluoro-4-methoxyphenyl)methyl]amine | C10H14FNO | 851903-83-8 | Details |
| EFHC1 antibody | Details |
| N-[(4-Methylphenyl)sulfonyl]phenylalanine | C16H17NO4S | 34635-34-2 | Details |
| p-Sulfophenylazochromotropic acid trisodium salt | C16H13N2NaO11S3 | 23647-14-5 | Details |
| 4-cyclopropoxypyridin-2-amine | C8H10N2O | 1419223-87-2 | Details |
| Kaempferol di-o-methoxymethyl ether | C19H18O8 | 1329801-99-1 | Details |
| 4-(Methoxycarbonyl)-5-methyl-1H-pyrazole-3-carboxylic acid | C7H8N2O4 | 198135-11-4 | Details |
| 4-Chloro-1,1-dimethylfuro[3,4-c]pyridin-3(1H)-one | C9H8ClNO2 | 285991-71-1 | Details |
| OGG1 Blocking Peptide | Details |
| 3,5-Di-tert-butyl-4-hydroxybenzyl alcohol | C15H24O2 | 88-26-6 | Details |
| 2-[(5-Bromo-2-nitrophenyl)(methyl)amino]acetic acid | C9H9BrN2O4 | 305790-78-7 | Details |
| 5-Ethylindole-2-carboxylic acid | C11H11NO2 | 37033-93-5 | Details |
| 3-Chloro-8-bromo-4-hydroxyquinoline | C9H5BrClNO | 1204810-71-8 | Details |
| 4-Aminopyrimidine-2-carbonitrile | C5H4N4 | 245321-46-4 | Details |
| Chlamydia Trachomatis Antibody Positive Human Plasma | Details |
| Trypsin 3 protein | Details |
| tert-Butyl N-[5-(methylamino)pentyl]carbamate | C11H24N2O2 | 1311458-36-2 | Details |
| H-FLPEFGISSA-OH | Details |
| 4-Bromo-3-cyanotoluene | C8H6BrN | 42872-83-3 | Details |
| 1-Aminoazetidin-2-one hydrochloride | C3H7ClN2O | 1427379-16-5 | Details |
| (4,5-Dichloro-1-methyl-1H-pyrazol-3-yl)methanamine hydrochloride | C5H8Cl3N3 | 1431965-15-9 | Details |
| 8-Methyl-6-oxa-9-azaspiro[4.5]decane | C9H17NO | 1267693-75-3 | Details |
| 3-Chloro-2-methanesulfinylaniline | C7H8ClNOS | 1375471-66-1 | Details |
| 3-(2-Bromoethyl)-2H,3H-[1,3]oxazolo[4,5-b]pyridin-2-one | C8H7BrN2O2 | 134336-95-1 | Details |
| 3-Methyl-3-(2-methylpropyl)pyrrolidine-2,5-dione | C9H15NO2 | 1094231-95-4 | Details |
| 2-amino-7-methyl-5-oxo-4-(4-(trifluoromethoxy)phenyl)-4,6,7,8-tetrahydro2H-chromene-3-carbonitrile | C18H15F3N2O3 | 1024356-51-1 | Details |
| (4-Chlorophenyl)(3-iodophenyl)methanamine hydrochloride | 2230799-33-2 | Details |
| Neamine hydrochloride | C12H26N4O6.4ClH | 15446-43-2 | Details |
| Rubicordifolin | C33H28O9 | 849699-55-4 | Details |
| Methyl 2-cyano-5-fluorobenzoate | C9H6FNO2 | 606080-43-7 | Details |
| IDT 307 | C14H17IN2 | 1141-41-9 | Details |
| [2-Amino-2-(2-methylphenyl)ethyl]dimethylamine dihydrochloride | C11H20Cl2N2 | 2193059-62-8 | Details |
| Methyl 2-(3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)acetate | C12H12N2O3 | 28081-48-3 | Details |
| 4,6-Diamino-2-thiopyrimidine | C4H6N4S | 1004-39-3 | Details |
| Methyl 2-{[4-(4-methylphenyl)-3-oxo-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-5-yl]sulfanyl}acetate | C20H20N2O3S2 | 312625-68-6 | Details |
| Tert-butyl 4-hydroxy-1h-pyrazole-1-carboxylate | C8H12N2O3 | 1394947-77-3 | Details |
| JK-P3 | C18H17N3O3 | 942655-44-9 | Details |
| 3-Amino-3-(6-methoxy-pyridin-3-yl)-propionic acid | C9H12N2O3 | 773126-35-5 | Details |
| IMPA2 Blocking Peptide | Details |
| Closantel | C22H14Cl2I2N2O2 | 57808-65-8 | Details |
| 2-Bromo-7-chloro-[1,2,4]triazolo[1,5-a]pyridine | C6H3BrClN3 | 1504581-11-6 | Details |
| 3-[(2-Methylpropyl)sulfanyl]propan-1-amine | C7H17NS | 84155-46-4 | Details |
| N7-Benzylpyrimido[4,5-d]pyrimidine-2,4,7-triamine | C13H13N7 | 109160-46-5 | Details |
| Resorcinolnaphthalein | C24H14O5 | 41307-63-5 | Details |
| Berberine chloride hydrate | C20H20ClNO5 | 68030-18-2 | Details |
| TCP10L Blocking Peptide | Details |
| H-D-Leu-bNA·HCl | C16H21ClN2O | 201995-11-1 | Details |
| DRD1 antibody | Details |
| 3-Oxobicyclo[2.2.2]octane-1-carboxylic acid | C9H12O3 | 72764-22-8 | Details |
| CALCOCO1 antibody | Details |
| 7-Nitro-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one | C9H8N2O3S | 63928-35-8 | Details |
| IFN beta protein (Mouse) | Details |
| ZNF793 antibody | Details |
| Hemoglobin protein | Details |
| N-a-Boc-N-epsilon-cbz-L-lysine 4-nitroanilide | C25H32N4O7 | 51078-31-0 | Details |
| 4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzene-1-carboximidamide, acetic acid | C14H18N4O2 | 1909314-25-5 | Details |
| 4-(3-Bromophenyl)-2-(1H-pyrrol-2-yl)-1,3-thiazole hydrobromide | C13H10Br2N2S | 1909348-15-7 | Details |
| 2-(4-Oxo-3,4-dihydroquinazolin-3-yl)ethane-1-sulfonyl fluoride | C10H9FN2O3S | 885528-94-9 | Details |
| (2-Amino-3,4-dichlorophenyl)methanol | C7H7Cl2NO | 1595672-91-5 | Details |
| 2,2,2-Trifluoro-1-(1-methyl-1H-pyrrol-3-yl)ethan-1-amine | C7H9F3N2 | 511522-47-7 | Details |
| 2H-Perfluoro-2-dodecenoic acid | C12H2F20O2 | 70887-94-4 | Details |
| 2-Ethynyl-1H-indole | C10H7N | 75258-11-6 | Details |
| 4-Chloro-1-propyl-1H-pyrazole-5-sulfonyl chloride | C6H8Cl2N2O2S | 1245823-83-9 | Details |
| 3-(Propan-2-yl)bicyclo[1.1.1]pentan-1-amine hydrochloride | C8H16ClN | 1886967-00-5 | Details |
| Cathepsin B antibody (biotin) | Details |
| Z-Pro-Ala-OH | C16H20N2O5 | 14030-00-3 | Details |
| Aldol??518 beta-D-cellobioside, Biosynth Patent: EP 2427431 and US 8940909 | C35H39ClN2O12 | 2484872-99-1 | Details |
| 2,3-Dimethyl-2,3-butanediamine dihydrochloride | C6H18Cl2N2 | 75804-28-3 | Details |
| 3-(Aminomethyl)-2,5-dihydro-1,2,4-oxadiazol-5-one hydrochloride | C3H6ClN3O2 | 1423025-40-4 | Details |
| GNAZ antibody | Details |
| CYB5 antibody (FITC) | Details |
| Ent atomoxetine-d3, hydrochloride | C17H22ClNO | 1217703-95-1 | Details |
| 3-Bromo-2-(tert-butoxy)pyridine | C9H12BrNO | 1245898-81-0 | Details |
| 3-Amino-5,7-dimethyladamantane-1-carboxylic acid | C13H21NO2 | 14664-67-6 | Details |
| Tri-6(Z),9(Z),12(Z)-octadecatrienoin | C57H92O6 | 60756-74-3 | Details |
| 5,6,7,8-Tetrahydro-1,5-naphthyridine-2-carboxylic acid hydrochloride | C9H11ClN2O2 | 1909312-57-7 | Details |
| 3-Chloro-2-(propan-2-yloxy)aniline | C9H12ClNO | 130566-34-6 | Details |
| N-Acetylneuraminyl-(a2-3)-D-galactopyranosyl-(b1-3)-[N-acetylneuraminyl-(a2-6)]-D-N-acetylgalactosaminyl serine-biotin | Details |
| Methyl 3h-benzo[e]indole-2-carboxylate | C14H11NO2 | 55970-06-4 | Details |
| 1,1,1-Trifluoro-2-phenylpropan-2-amine | C9H10F3N | 177180-74-4 | Details |
| EEN antibody | Details |
| Recombinant SARS-CoV-2, RBD Protein (Alpha, B1.1.7, UK Variant) | Details |
| [1-(Oxiran-2-yl)cyclobutyl]methanol | 2305251-98-1 | Details |
| 4-Difluoromethoxy-3-methoxybenzylamine hydrochloride | C9H12ClF2NO2 | 1431966-33-4 | Details |
| Benzyl 2-{[(tert-butoxy)carbonyl](methyl)amino}prop-2-enoate | C16H21NO4 | 94882-76-5 | Details |
| Furo[2,3-b]pyridine-2-carbaldehyde | C8H5NO2 | 109274-92-2 | Details |
| 5-(3-Hydroxypropyl)-1,2-oxazole-3-carboxylic acid | C7H9NO4 | 1897744-26-1 | Details |
| Recombinant Mouse NGF R | Details |
| CACHD1 antibody | Details |
| Product Total： Product Page： | ||||
| 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 | ||||